This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
AI-Generated Summary This article by infectious diseases pharmacist Aneeka Chavda outlines five key considerations for pharmacists in the treatment of Mycobacterium tuberculosis (TB), particularly drug-sensitive cases. The piece advocates for therapeutic drug monitoring (TDM) in specific high-risk groups to personalize treatment.
Tarlatamab established a new standard for relapsed SCLC, with improved survival and easier administration, enhancing treatment accessibility. Zanubrutinib demonstrated sustained efficacy in CLL with del(17p), emphasizing the importance of BTK inhibitors in high-risk hematologic malignancies.
Pharmacists are key in advising on self-care, prevention, and OTC product selection for mild to moderate contact dermatitis. Pharmacists are key in advising on self-care, prevention, and OTC product selection for mild to moderate contact dermatitis. SHOW MORE Prompt identification and appropriate clinical intervention are critical.
Malesker, PharmD, FCCP, FCCM, FASHP, BCPS +1 More Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action. Jansen, PharmD Candidate , Mark A.
These technologies prevent the risk of both hypo- and hyperglycemic episodes, facilitating safer fasting. The guidance is updated every 5 years, with the most recent update published in May 2025. Monitoring technology is valuable to assess glycemic control and enable timely interventions in T1D patients.
SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. Transportation barriers, as a health-related social need, significantly impact FN rates in chemotherapy patients. Febrile neutropenia (FN) remains a serious and common complication of chemotherapy.
The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target." It is not indicated for type 1 diabetes and carries a boxed warning for thyroid C-cell tumors, with unknown risk in humans.
Cardiovascular disease risks in HIV patients have evolved with ART, requiring preventive measures like statins and cardiovascular risk scores for effective management.
Anti-TNFs remain the only FDA-approved class for pediatric IBD, prompting biosimilar use for cost and accessibility. Further research is needed on the clinical impact, treatment longevity, and cost implications of biosimilar use in pediatric IBD.
Understanding and addressing barriers to medication adherence are crucial for effective treatment of psychiatric disorders and improving patient outcomes. Long-acting injectable antipsychotics may improve adherence in homeless populations, but transportation and clinic visit logistics must be considered.
The FDA's fast track designation highlights birelentinib's potential to meet unmet needs in CLL/SLL treatment. SHOW MORE Birelentinib gains FDA fast track designation, offering hope for relapsed CLL/SLL patients resistant to current BTK and BCL-2 therapies.
Even in full-term, healthy pregnancies, maternal health conditions including hypothyroidism, hormonal imbalances and PCOS (especially if they occurred during puberty), and many others can prevent or delay the production of breast milk. A practitioner will help assess individual patients to determine if or when breastfeeding is advised. [11]
COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. The initial pandemic lockdowns prevented many patients from seeing doctors face-to-face. The scope of the problem.
1 , 4 A Retrospective Journey In 2015, Vertex’s Orkambi was the first approved drug produced under a CM process for the treatment of cystic fibrosis. Table 1: List of FDA-approved commercial products using CM elements. Table 1: List of FDA-approved commercial products using CM elements. This is demonstrated by the rise from $1.05
In fact, most people who are diagnosed with Hashimoto’s will present with low levels of ferritin, the iron storage protein that is important for proper thyroid function – but of course, most don’t get tested properly. Again, I don’t recommend supplementing with iron unless you’ve been tested and deemed as deficient.
Experts believe that this medicine can be highly effective against parasites present inside and outside the body. Additionally, this drug is also known as anti-parasite successful against all viruses like HIV, Dengue, Influenza , and Zika virus. And stated its judicial use in preventing corona infection. So, we’ve learned that.
The next phase of the Covid-19 – from vaccines to treatments. This response is at a speed that would be considered unthinkable pre-pandemic, but, given a highly transmissible variant and the ever-present threat of new variants of concern, it may still not be fast enough. This may pose a barrier to effective use.
Nikolai Lazarev defined adaptogens as “an agent that raises the body’s ability to resist stress by countering undesired stressors, whether physical, chemical, emotional, or biological.” Would you like to know if adaptogenic herbs might be of benefit to you? This can also mean fewer nutrients are absorbed.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content